Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

Open Access Email this article to a friend

No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial

Robert Eggertsen*, Åke Andreasson and Lennart Andrén

BMC Pharmacology and Toxicology 2012, 13:10  doi:10.1186/2050-6511-13-10

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Pharmacology and Toxicology's emails?